Home Covid-19
The lung disease Covid-19, which is caused by the novel coronavirus known as SARS-CoV-2, has the world in its grip. GBN is bringing biobanks and researchers together to gain insights into the disease and develop treatments.
See here for information on handling biosamples as well as further literature.
From swabs to whole blood – these German biobanks are collecting SARS-CoV-2 samples.
11/24/2023
12 Mitarbeiterinnen verschiedener GBA-Biobanken beteiligen sich ab dem kommenden Jahr an der Durchführung der internen „Friendly Audits“.
10/11/2023
"The meeting not only provided an opportunity for professional exchange, but also created an atmosphere of collegial cooperation," said Michael Hummel.
10/10/2023
Representatives from GBN/GBA and patient groups have written a joint statement. They are now looking for supporters.
germanbiobanknode@charite.de
Tel. +49. 30. 450 536 347
Fax +49. 30. 450 753 69 38
© 2023 All rights reserved.
